Beranda2AB • FRA
add
Barinthus Biotherapeutics PLC - ADR
Tutup sebelumnya
€0,78
Rentang hari
€0,82 - €0,82
Rentang tahun
€0,57 - €2,14
Kapitalisasi pasar
38,73Â jt USD
Rasio P/E
-
Hasil dividen
-
Bursa utama
NASDAQ
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
(USD) | Des 2024info | Perubahan Y/Y |
---|---|---|
Pendapatan | 0,00 | — |
Biaya operasional | 2,60Â jt | -86,22% |
Laba bersih | -20,54Â jt | -18,78% |
Margin laba bersih | — | — |
Penghasilan per saham | -0,20 | 55,09% |
EBITDA | -2,04Â jt | 89,17% |
Tarif pajak efektif | -0,01% | — |
Neraca
Total aset
Total liabilitas
(USD) | Des 2024info | Perubahan Y/Y |
---|---|---|
Investasi tunai jangka pdk | 110,66Â jt | -22,12% |
Total aset | 160,33Â jt | -25,26% |
Total liabilitas | 30,19Â jt | 9,75% |
Total ekuitas | 130,14 jt | — |
Saham yang beredar | 40,34 jt | — |
Harga terhadap nilai buku | 0,24 | — |
Tingkat pengembalian aset | -3,82% | — |
Tingkat pengembalian modal | -4,24% | — |
Arus Kas
Perubahan kas bersih
(USD) | Des 2024info | Perubahan Y/Y |
---|---|---|
Laba bersih | -20,54Â jt | -18,78% |
Kas dari operasi | 13,09Â jt | 166,76% |
Kas dari investasi | -278,00Â rb | -281,70% |
Kas dari pembiayaan | 837,00Â rb | 667,89% |
Perubahan kas bersih | 6,30Â jt | 134,57% |
Arus kas bebas | 14,35Â jt | 171,38% |
Tentang
Barinthus Biotherapeutics plc is a biotechnology company developing immunotherapies for infectious diseases, cancer and autoimmune diseases such as hepatitis B, HPV and prostate cancer. Formerly known as Vaccitech plc, in November 2023 the company announced that it had renamed itself to Barinthus Biotherapeutics plc. As of 2024, the company employs more than 100 people. Wikipedia
Didirikan
2016
Situs
Karyawan
105